BioSpace News Archive

Policy

Congress Debates Reauthorization of FDA User Fees as Deadline Looms

The Sept. 30 deadline for Congress to reauthorize the FDA’s prescription drug user fee is looming, while advocates and detractors are debating the merits of the funding source.

September 15, 2022
·
3 min read
·
Alex Keown
Business

With $100M, Galvanize Absorbs Two Biotechs to Advance Electric Pulse Therapies

Gala Therapeutics and Galaxy Medical will be folded into Galvanize Therapeutics to continue to develop their electric pulse therapies for bronchitis, cardiac arrhythmias and solid tumors.

September 15, 2022
·
1 min read
·
Paul Elias
Genetown

Biophytis Participates in H.C. Wainwright 24th Annual Global Investment Conference

Biophytis SA made a presentation to investors on the 12th of September in New York, on the occasion of the 24th Global Investment Conference organised by the HC Wainwright bank, which is being held from 12 to 14 September 2022 in New York.

September 15, 2022
·
4 min read
Hexvix®, A Diagnostic Drug of Asieris, is Now Covered by the 2022 Lecheng Global Specialty Drug Insurance

Asieris Pharmaceuticals announced that Hexvix®, a drug used for bladder cancer diagnosis, has been included in the 2022 edition of the Lecheng Global Specialty Drug Insurance Specialty Drug List.

September 15, 2022
·
4 min read
Drug Development

BrainStorm Cell Therapeutics Announces Peer Reviewed Publication of Results from the NurOwn® Phase 2 Progressive MS Trial in Multiple Sclerosis Journal

BrainStorm Cell Therapeutics Inc. announced the peer reviewed publication of data from the Phase 2 trial of NurOwn in progressive multiple sclerosis in Multiple Sclerosis Journal.

September 15, 2022
·
11 min read
Pharm Country

Co-Author of the Karolinska 1000 Consecutive MANTA® Vascular Closure Device Study to Present Learnings at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference

Teleflex Incorporated announced that Dr. Magnus Settergren*, Asssociate Professor at the Karolinska Institutet, Interventional Cardiologist at Karolinska University Hospital is scheduled to present at a Teleflex-sponsored Training Pavilion at the Transcatheter Cardiovascular Therapeutics conference.

September 15, 2022
·
5 min read
Business

Caris Life Sciences Announces Appointment of Russ Denton as General Counsel

Caris Life Sciences® announced that Russ Denton has joined the company as Senior Vice President, General Counsel and Secretary, and will lead Caris’ legal and corporate governance efforts.

September 15, 2022
·
2 min read
Drug Development

Pfizer Announces Positive Top-Line Results from Phase 3 Trial of Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents

Pfizer Inc. announced positive top-line results from the pivotal Phase 3 trial assessing the safety, tolerability, and immunogenicity of its investigational pentavalent meningococcal vaccine in healthy individuals 10 through 25 years of age.

September 15, 2022
·
12 min read
Drug Development

Excision BioTherapeutics Doses First Participant in EBT-101 Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV

Excision BioTherapeutics, Inc., a clinical-stage biotechnology company developing CRISPR-based therapies intended to cure viral infectious diseases, today announced that the first participant has been dosed in the Phase 1/2 clinical trial of EBT-101 for human immunodeficiency virus type 1 (HIV-1).

September 15, 2022
·
5 min read
Pharm Country

Tonix Pharmaceuticals Announces Data Presentations Involving TNX-1500 (Fc-Modified Anti-CD40L mAb) for the Prevention of Rejection in Allograft and Xenograft Transplantation in Animal Models at the International Congress of TTS 2022

Tonix Pharmaceuticals Holding Corp. announced data from three oral presentations by faculty at the Center for Transplantation Sciences, Massachusetts General Hospital Center at the 29th International Congress of The Transplantation Society held September 10-14, 2022 in Buenos Aires, Argentina.

September 15, 2022
·
6 min read